486 related articles for article (PubMed ID: 20225912)
1. Ratio of controller to total asthma medications: determinants of the measure.
Broder MS; Gutierrez B; Chang E; Meddis D; Schatz M
Am J Manag Care; 2010 Mar; 16(3):170-8. PubMed ID: 20225912
[TBL] [Abstract][Full Text] [Related]
2. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
Blanchette CM; Culler SD; Ershoff D; Gutierrez B
Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
[TBL] [Abstract][Full Text] [Related]
3. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
Ye X; Gutierrez B; Zarotsky V; Nelson M; Blanchette CM
Curr Med Res Opin; 2009 Sep; 25(9):2251-8. PubMed ID: 19622006
[TBL] [Abstract][Full Text] [Related]
4. Asthma costs and utilization in a managed care organization.
Zeiger RS; Hay JW; Contreras R; Chen W; Quinn VP; Seal B; Schatz M
J Allergy Clin Immunol; 2008 Apr; 121(4):885-92.e5. PubMed ID: 18313133
[TBL] [Abstract][Full Text] [Related]
5. Physician adherence to the national asthma prescribing guidelines: evidence from national outpatient survey data in the United States.
Navaratnam P; Jayawant SS; Pedersen CA; Balkrishnan R
Ann Allergy Asthma Immunol; 2008 Mar; 100(3):216-21. PubMed ID: 18426140
[TBL] [Abstract][Full Text] [Related]
6. Retrospective claims study of fluticasone propionate/salmeterol fixed-dose combination use as initial asthma controller therapy in children despite guideline recommendations.
Friedman HS; Eid NS; Crespi S; Wilcox TK; Reardon G
Clin Ther; 2009 May; 31(5):1056-63. PubMed ID: 19539106
[TBL] [Abstract][Full Text] [Related]
7. Adherence to inhaled corticosteroid use and local adverse events in persistent asthma.
Ivanova JI; Birnbaum HG; Hsieh M; Yu AP; Seal B; van der Molen T; Emani S; Rosiello RA; Colice GL
Am J Manag Care; 2008 Dec; 14(12):801-9. PubMed ID: 19067497
[TBL] [Abstract][Full Text] [Related]
8. Asthma rescue and allergy medication use among asthmatic children with prior allergy prescriptions who initiated asthma controller therapy.
Luskin A; Bukstein D; Kocevar VS; Yin DD
Ann Allergy Asthma Immunol; 2005 Aug; 95(2):129-36. PubMed ID: 16136761
[TBL] [Abstract][Full Text] [Related]
9. Uncontrolled asthma in a commercially insured population from 2002 to 2007: trends, predictors, and costs.
Sawicki GS; Vilk Y; Schatz M; Kleinman K; Abrams A; Madden J
J Asthma; 2010 Jun; 47(5):574-80. PubMed ID: 20560831
[TBL] [Abstract][Full Text] [Related]
10. Patient characteristics and prescription fill patterns for allergic rhinitis medications, with a focus on montelukast, in a commercially insured population.
Bollinger ME; Diette GB; Chang CL; Stephenson JJ; Sajjan SG; Fan T; Allen-Ramey FC
Clin Ther; 2010 Jun; 32(6):1093-102. PubMed ID: 20637964
[TBL] [Abstract][Full Text] [Related]
11. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids.
Friedman HS; Yawn BP
Curr Med Res Opin; 2007 Feb; 23(2):427-34. PubMed ID: 17288696
[TBL] [Abstract][Full Text] [Related]
12. Asthma-related health care resource use among patients starting fluticasone or montelukast therapy.
Allen-Ramey FC; Anstatt DT; Sajjan SG; Markson LE
Pharmacotherapy; 2005 Dec; 25(12):1752-60. PubMed ID: 16305295
[TBL] [Abstract][Full Text] [Related]
13. Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma.
Delea TE; Hagiwara M; Stanford RH; Stempel DA
Clin Ther; 2008 Mar; 30(3):560-71. PubMed ID: 18405796
[TBL] [Abstract][Full Text] [Related]
14. Medication compliance and disease exacerbation in patients with asthma: a retrospective study of managed care data.
Stern L; Berman J; Lumry W; Katz L; Wang L; Rosenblatt L; Doyle JJ
Ann Allergy Asthma Immunol; 2006 Sep; 97(3):402-8. PubMed ID: 17042149
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of risk factors and health outcomes among persons with asthma.
Smith K; Warholak T; Armstrong E; Leib M; Rehfeld R; Malone D
J Asthma; 2009 Apr; 46(3):234-7. PubMed ID: 19373629
[TBL] [Abstract][Full Text] [Related]
16. Costs and resource use of mild persistent asthma patients initiated on controller therapy.
Colice GL; Yu AP; Ivanova JI; Hsieh M; Birnbaum HG; Lage MJ; Brewster C
J Asthma; 2008 May; 45(4):293-9. PubMed ID: 18446593
[TBL] [Abstract][Full Text] [Related]
17. Inhaled corticosteroid use and outcomes in pregnancy.
Schatz M; Leibman C
Ann Allergy Asthma Immunol; 2005 Sep; 95(3):234-8. PubMed ID: 16200813
[TBL] [Abstract][Full Text] [Related]
18. Increasing pharmaceutical copayments: impact on asthma medication utilization and outcomes.
Campbell JD; Allen-Ramey F; Sajjan SG; Maiese EM; Sullivan SD
Am J Manag Care; 2011 Oct; 17(10):703-10. PubMed ID: 22106463
[TBL] [Abstract][Full Text] [Related]
19. The utility of the Health Plan Employer Data and Information Set (HEDIS) asthma measure to predict asthma-related outcomes.
Berger WE; Legorreta AP; Blaiss MS; Schneider EC; Luskin AT; Stempel DA; Suissa S; Goodman DC; Stoloff SW; Chapman JA; Sullivan SD; Vollmer B; Weiss KB
Ann Allergy Asthma Immunol; 2004 Dec; 93(6):538-45. PubMed ID: 15609762
[TBL] [Abstract][Full Text] [Related]
20. Inhaled corticosteroids vs leukotriene receptor antagonists: health care costs across varying asthma severities.
O'Connor RD; Parasuraman B; Roberts C; Leibman C
Ann Allergy Asthma Immunol; 2006 Aug; 97(2):236-43. PubMed ID: 16937758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]